Vancomycin Dosing for MRSA Infections

Standard Dosing Regimen

The Infectious Diseases Society of America recommends vancomycin dosing at 15-20 mg/kg (actual body weight) every 8-12 hours, not exceeding 2 g per dose, with target trough concentrations of 15-20 μg/mL for serious infections 1, 2
For non-severe infections in non-obese patients with normal renal function, traditional doses of 1 g every 12 hours may be adequate, according to Praxis Medical Insights 3

A loading dose of 25-30 mg/kg (actual body weight) should be considered for seriously ill patients with sepsis, meningitis, pneumonia, or infective endocarditis, as recommended by the Infectious Diseases Society of America 1, 2, 3
This loading dose rapidly achieves therapeutic concentrations in critically ill patients with expanded volumes of distribution due to fluid resuscitation, according to Praxis Medical Insights 3

Trough vancomycin concentrations are the most accurate and practical method to guide dosing, as stated by Praxis Medical Insights 3
Target trough concentrations are 15-20 μg/mL for serious infections, such as bacteremia, endocarditis, meningitis, pneumonia, and osteomyelitis, as recommended by the Infectious Diseases Society of America 1, 2, 3
The pharmacodynamic parameter that best predicts efficacy is AUC/MIC ratio >400, according to the Infectious Diseases Society of America 1, 3

Clinical response should determine continued vancomycin use when MIC <2 μg/mL, as recommended by the Infectious Diseases Society of America 1, 2
For isolates with vancomycin MIC >2 μg/mL (VISA or VRSA), an alternative to vancomycin should be used, according to the Infectious Diseases Society of America and Praxis Medical Insights 1, 2, 3

For persistent MRSA bacteremia or vancomycin treatment failures, high-dose daptomycin (10 mg/kg/day) in combination with another agent should be considered, as recommended by the Infectious Diseases Society of America 1, 2
Combination options include gentamicin, rifampin, linezolid, or TMP-SMX, according to the Infectious Diseases Society of America 1, 2

For MRSA bacteremia and endocarditis, IV vancomycin for 4-6 weeks is recommended, as stated by the Infectious Diseases Society of America 1, 2